IMRX
Immuneering Corp
4.60$
+3.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.14 | 0.17 | 0.08 | 0.01 | 0.00 | 0.00 | 0.00 | |
| 0.09 | 0.09 | 0.04 | 0.01 | 0.03 | 0.02 | 0.02 | |
| 0.05 | 0.08 | 0.04 | 0.01 | -0.03 | -0.02 | -0.02 | |
| 0.32 | 1.11 | 1.01 | 1.37 | 1.46 | 1.60 | 0.96 | |
| 0.20 | 0.23 | 0.31 | 0.59 | 0.59 | 0.54 | 0.39 | |
| 0.52 | 1.34 | 1.32 | 1.97 | 2.06 | 2.14 | 1.33 | |
| -0.47 | -1.26 | -1.29 | -1.96 | -2.06 | -2.14 | -1.35 | |
| 0.03 | 0.00 | 0.01 | 0.04 | – | – | – | |
| -0.57 | -1.27 | -1.29 | -1.91 | -1.88 | -2.04 | -1.27 | |
| 0.03 | -0.01 | -0.01 | -0.05 | 0.00 | – | – | |
| -0.57 | -1.26 | -1.27 | -1.91 | -1.88 | -2.04 | -1.27 | |
| -0.54 | -1.26 | -1.28 | -1.95 | -2.04 | -2.12 | -1.26 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.